Autoimmune Pancreatitis. (September 2018)

• Record Type: Journal Article
• Authors: Nagpal, Sajan Jiv Singh; Sharma, Ayush; Chari, Suresh T.
• Is Part Of: American journal of gastroenterology. Volume 113:Number 9(2018)
• Publication Date: 2018-09
• Subjects: Stomach -- Diseases -- Periodicals; Intestines -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Gastrointestinal Diseases -- Periodicals; Electronic journals; Periodicals; 616.33
• DOI: 10.1038/s41395-018-0146-0
• Languages: English
• ISSNs: 0002-9270

Abstract

Abstract : N/A: Over the course of the last 2 decades our knowledge of autoimmune pancreatitis has increased exponentially. In this review, we summarize the clinical presentation, diagnosis and treatment of AIP, to better allow general gastroenterologists and primary care providers to consider AIP as a as a rare but important cause of painless obstructive jaundice and recurrent acute pancreatitis. While steroids remain the mainstay of first line therapy, a number of patients with type 1 AIP require immunomodulators or rituximab to maintain remission; recommendations on the management of relapses continue to evolve.